Initially there was no specific way to reverse well you know I mean like so the anticoagulant effect of dabigatran in the event of a well okay well uh um major bleeding event, unlike for warfarin, but a like like I mean um uh dabigatran antidote (idarucizumab) was approved by the FDA in 2015.